New asthma inhaler tested in teens: early safety check

NCT ID NCT07065331

First seen Jun 27, 2026 ยท Last updated Jun 27, 2026

Summary

This early-stage study tested a single inhaled dose of a new drug called AZD8630 in 10 teenagers with asthma. The main goal was to see how the drug moves through the body and to check for any safety issues. Participants used a dry powder inhaler and were monitored for side effects and immune reactions.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary โ€” we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ASTHMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

asthma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Research Site

    Bakersfield, California, 93301, United States

  • Research Site

    Miami Lakes, Florida, 33014, United States

  • Research Site

    Lafayette, Louisiana, 70508, United States

  • Research Site

    Raleigh, North Carolina, 27607, United States

  • Research Site

    Toledo, Ohio, 43617, United States

  • Research Site

    Oklahoma City, Oklahoma, 73120, United States

  • Research Site

    Spartanburg, South Carolina, 29303, United States

  • Research Site

    Boerne, Texas, 78006, United States

  • Research Site

    Salt Lake City, Utah, 84107, United States